关键数据
0.440今开
0.418最高
100.00成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.00%换手率
0.420昨收
0.418最低
41.80成交额
亏损市盈率静
2.88市净率
0.00%股息率 TTM
-310.39%ROA
4.00052周最高
0.00量比
-19.45M净利润
56.35M总股本
-0.5587每股收益TTM
-0.86Beta
-495.61%ROE
0.39052周最低
0.00%振幅
--毛利率
23.55M总市值
-1.71回报/风险
9.43%风险率

即将为您带来更多新闻,敬请期待。。。
分析师评级
买入评级
3.167目标均价
+645.10%涨幅空间
Heartbeam Inc 最新财报电话会记录
HeartBeam (BEAT) 2026年第二季度业绩电话会:FDA申报,降低现金消耗与商业化启动
HeartBeam 的 2026 年第二季度业绩电话会议涵盖了 500 万美元的净亏损、现金消耗减少、FDA 进展以及在美国四个市场的早期商业化推广。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Heartbeam Inc 简介
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
行业医疗设备与耗材
公司代码BEAT
员工数量21
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Strome Mezzanine Fund, L.P. | 5.87% |
|---|
| Schwartzberg (Andrew) | 3.54% |
|---|
| Vanguard Capital Management, LLC | 2.23% |
|---|
| Public Ventures LLC | 1.99% |
|---|
| 股东类型 | 占比 |
|---|
| Individual Investor | 8.06% |
|---|
| Corporation | 7.86% |
|---|
| Investment Advisor | 7.40% |
|---|
| Investment Advisor/Hedge Fund | 1.15% |
|---|
常见问题
Heartbeam Inc(BEAT)的当前股价是多少?
Heartbeam Inc(BEAT)的当前股价是 0.42。
Heartbeam Inc股票的52周最高点是多少?
Heartbeam Inc股票的52周最高点是4.00。
Heartbeam Inc股票的52周最低点是多少?
Heartbeam Inc股票的52周最低点是0.39。
现在Heartbeam Inc(BEAT)的股票是买入、持有还是卖出?
根据分析师评级,Heartbeam Inc(BEAT)的总体评级为买入,目标价格为3.17。
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是多少
Heartbeam Inc(BEAT)股票的每股收益(EPS TTM)是-0.56。